P38-MAP-KINASE-INHIBITOREN

European patent · EP2370428 · In force

Register entry

Publication number
EP2370428
Application number
EP09768546
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 11, 2009
Published
Oct 5, 2011
Granted
Aug 10, 2016
Protection ends at the latest
Dec 10, 2029
Next annual fee due
Dec 31, 2026
IPC classes
C07D 401/12 (2006.01)
C07D 401/14 (2006.01)
A61K 31/415 (2006.01)
A61P 11/00 (2006.01)
A61P 29/00 (2006.01)
Priority
GB 0822609 11.12.2008
US 166594 P 03.04.2009
GB 0912470 17.07.2009
PCT application
PCT/GB2009/051703 11.12.2009
PCT publication
WO2010/067131 17.06.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Aug 10, 2016

    Granted

    Published in Swissreg on 10.08.2016

Parties

Holder

Respivert Limited

50-100 Holmers Farm Way, High Wycombe Buckinghamshire HP12 4EG, GB

Inventor

ITO, Kazuhiro

London SW7 2AZ, GB

STRONG, Peter

London SW7 2AZ, GB

RAPEPORT, William, Garth

London SW7 2AZ, GB

MURRAY, Peter, John

London SW7 2AZ, GB

KING-UNDERWOOD, John

Pendock Worcestershire GL19 3PW, GB

WILLIAMS, Jonathan, Gareth

Nottingham NG1 1GF, GB

ONIONS, Stuart, Thomas

Nottingham NG1 1GF, GB

HIRST, Simon Christopher

Nottingham NG1 1GF, GB

TADDEI, David, Michel, Adrien

Nottingham NG1 1GF, GB

CHARRON, Catherine, Elisabeth

London SW7 2AZ, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.